Published in Cancer Weekly, May 1st, 2006
According to recent research from the Netherlands, "The aim of this study was to (1) assess the QoL of testicular cancer survivors (TCSs) by comparing them to a reference group; (2) investigate the relationship between the QoL of TCSs and sociodemographics, cancer-related variables, and life events; and (3) identify TCSs at risk for an impaired QoL. Of the TCSs approached, 50% (n=354) participated and completed a generic QoL questionnaire (RAND-36) once."
"Time since completion of treatment varied from 3 months to 24 years," explained J. Fleer and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.